We’re on the Path to Eradicate Gynecologic Cancers
The Society of Gynecologic Oncology (SGO) corporate partners have supported SGO’s mission to more effectively treat and eliminate gynecologic cancers. We alone cannot address these challenges faced in the treatment and prevention of women’s cancer. SGO welcomes the collaborative thinking of our corporate partners in order to eliminate these diseases during our lifetime.
Industry Corporate Council
Comprised of select leaders in the pharmaceutical and device industry, the SGO Industry Corporate Council is a means for SGO leaders and its industry partners to focus on issues and initiatives of mutual concern in gynecologic cancers.
Annual Membership ($50,000)
Exclusive access to and knowledge of SGO’s current endeavors and plans for the future
Increased exposure and visibility to the complete women’s cancer care team of professionals
Enhanced access to SGO’s leaders in private practice and those in major academic and research institutions
A consistent, reliable forum to meet and discuss issues that relate to the importance of the profession, women’s cancer care and the industry that provides vital treatment and prevention tools
Regular, specific correspondence about SGO activities and initiatives relevant to your business and to our profession
To inquire about the SGO Industry Corporate Council, please contact Teri Jordan.
Benefits of Membership
Opportunities to share input on mutual concerns in gynecologic oncology
Two to three representatives to serve and discuss key issues facing the subspecialty two times a year.
Advanced analytics (open rate, number of logo clicks and survey results)
Email marketing to SGO members
Webinar attendee mailing list
Ability to provide brief exit survey at the conclusion of the webinar
To inquire about sponsorship opportunities, please contact Teri Jordan.
SGO Member Demographics
96% of the members are U.S.-based and 4% are international representing 35 countries
Members include gynecologic oncologists (67%), medical oncologists (2%), pathologists (1%), radiation oncologists (1%), obstetrician/gynecologists (1%), nurse practitioners (2%), physician assistants (2%), fellows-in-training (10%), residents (5%) and other allied health care professionals (9%) interested in the treatment and care of gynecologic cancer
SGO members provide multidisciplinary cancer treatment including chemotherapy, radiation therapy, surgery and supportive care